Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension
Rajkumar Savai(Goethe University Frankfurt), Ralph T. Schermuly(Justus-Liebig-Universität Gießen), Werner Seeger(Justus-Liebig-Universität Gießen), Walter Klepetko(Medical University of Vienna), A. Scheed(Medical University of Vienna), Robert Voswinckel(Justus-Liebig-Universität Gießen), Soni Savai Pullamsetti(Justus-Liebig-Universität Gießen), Norbert Weißmann(Cardio-Pulmonary Institute), Christin Ritter, Hossein Ardeschir Ghofrani(Justus-Liebig-Universität Gießen), Friedrich Grimminger(Justus-Liebig-Universität Gießen), Ludger Fink(Institute of Cytology), Gamal Andre Banat, Bhola K. Dahal, Julia Kolbe, Ewa Bieniek, Sven Klußmann(Aptar (Germany)), Axel Vater(Noxxon Pharma (Germany))
American Journal of Respiratory and Critical Care Medicine
September 7, 2012
Cited by 411
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Reversal of experimental pulmonary hypertension by PDGF inhibition
|Journal of Clinical Investigation|2005|1.1k